 | Mohammad Hirmand, M.D. Vice President, Clinical Development Dr. Hirmand joined Medivation as senior director, clinical development in August 2007 and was promoted to vice president, clinical development in February 2008. Before joining the Company, he was a senior director of clinical development at Nuvelo, Inc., where he led the clinical development department comprised of clinical operations, clinical data management and clinical sciences/medical monitor staff. Before that, he served as director of oncology development at SuperGen, Inc. and as associate director of clinical research at Amgen, Inc. (formerly Tularik, Inc.), where he led clinical development efforts for Tularik’s oncology trials. Earlier in his career, he was a clinical scientist and manager of market development and product evaluation at Theravance, Inc. Dr. Hirmand received his M.D. from Harvard Medical School. Top |
|
